The Potential Therapeutic Prospect of PANoptosis in Heart Failure

Abstract Heart failure (HF) represents a serious manifestation or advanced stage of various cardiac diseases. HF continues to impose a significant global disease burden, characterized by high rates of hospitalization and fatality. Furthermore, the pathogenesis and pathophysiological processes underlying HF remain incompletely understood, complicating its prevention and treatment strategies. One significant pathophysiological mechanism associated with HF is the systemic inflammatory response. PANoptosis, a novel mode of inflammatory cell death, has been extensively studied in the context of infectious diseases, neurodegenerative disorders, cancers, and other inflammatory conditions. Recent investigations have revealed that PANoptosis-related genes are markedly dysregulated in HF specimens. Consequently, the PANoptosis-mediated inflammatory response may represent a potential mechanism and therapeutic target for HF. This paper conducts a comprehensive analysis of the molecular pathways that drive PANoptosis. We discuss its role and potential therapeutic targets in HF, thereby providing valuable insights for clinical treatment and the development of novel therapies.

• Publication year

  2024

• Venue

  Journal of Inflammation Research

• Publication date

  2024-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2147/JIR.S485901PMID 39583864PMCID 11585275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigation of polysaccharide from Radix Aconiti Lateralis Preparata (Fuzi) cardio protective effect on doxorubicin-induced chronic cardiotoxicity.

  2024cited by this paper
• Regulation of Optimized New Shengmai Powder on cardiomyocyte apoptosis and ferroptosis in ischemic heart failure rats: the mediating role of phosphatidylinositol-3-kinase/protein kinase B/tumor protein 53 signaling pathway.

  2024cited by this paper
• Protective effects of curcumin on corneal endothelial cell PANoptosis and monocyte adhesion induced by tumor necrosis factor-alpha and interferon-gamma in rats.

  2024cited by this paper
• Curcumin-primed olfactory mucosa-derived mesenchymal stem cells mitigate cerebral ischemia/reperfusion injury-induced neuronal PANoptosis by modulating microglial polarization.

  2024cited by this paper
• Shengxian decoction improves lung function in rats with bleomycin-induced idiopathic pulmonary fibrosis through the inhibition of PANoptosis.

  2024cited by this paper
• The role of pyroptosis in heart failure and related traditional chinese medicine treatments

  2024cited by this paper
• Targeting the PANoptosis signaling pathway for myocardial protection: therapeutic potential of Xian Ling Gu Bao capsule

  2024cited by this paper
• ZBP1-mediated PANoptosis: A possible novel mechanism underlying the therapeutic effects of penehyclidine hydrochloride on myocardial ischemia-reperfusion injury.

  2024cited by this paper
• Chronic Mitochondrial Dynamic-Targeted Therapy Alleviates Left Ventricular Dysfunction by Reducing Multiple Programmed Cell Death in Post-Myocardial Infarction Rats.

  2024cited by this paper
• The mechanosensitive Piezo1 channel exacerbates myocardial ischaemia/reperfusion injury by activating caspase-8-mediated PANoptosis.

  2024cited by this paper
• Scutellarin inhibits inflammatory PANoptosis by diminishing mitochondrial ROS generation and blocking PANoptosome formation.

  2024cited by this paper
• The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial

  2024cited by this paper
• Dachengqi decoction dispensing granule ameliorates LPS-induced acute lung injury by inhibiting PANoptosis in vivo and in vitro.

  2024cited by this paper
• In vivo and in vitro study on the regulatory mechanism of XiaoChaiHu decoction on PANoptosis in sepsis-induced cardiomyopathy.

  2024cited by this paper
• Baicalin inhibits PANoptosis by blocking mitochondrial Z-DNA formation and ZBP1-PANoptosome assembly in macrophages

  2024cited by this paper
• TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways

  2024cited by this paper
• Quercetin attenuates SiO2-induced ZBP-1-mediated PANoptosis in mouse neuronal cells via the ROS/TLR4/NF-κb pathway.

  2024cited by this paper
• Transcriptomic analysis reveals molecular characterization and immune landscape of PANoptosis-related genes in atherosclerosis

  2024cited by this paper
• Si-Wu-Tang attenuates hepatocyte PANoptosis and M1 polarization of macrophages in non-alcoholic fatty liver disease by influencing the intercellular transfer of mtDNA.

  2024cited by this paper
• Kongensin a attenuates intervertebral disc degeneration by inhibiting TAK1-mediated PANoptosis of nucleus pulposus cells.

  2024cited by this paper
• Effect of lipopolysaccharide on TAK1-mediated hepatocyte PANoptosis through Toll-like receptor 4 during acute liver failure.

  2024cited by this paper
• Genetic inactivation of β-catenin is salubrious whereas its activation is deleterious in desmoplakin cardiomyopathy.

  2023cited by this paper
• Quantifying inflammation using interleukin‐6 for improved phenotyping and risk stratification in acute heart failure

  2023cited by this paper
• A Pilot Study About the Role of PANoptosis-Based Genes in Atherosclerosis Development

  2023cited by this paper
• N-arachidonoylphenolamine alleviates ischaemia/reperfusion-induced cardiomyocyte necroptosis by restoring proteasomal activity.

  2023cited by this paper
• Bardoxolone methyl attenuates doxorubicin‐induced cardiotoxicity by inhibiting the TXNIP–NLRP3 pathway through Nrf2 activation

  2023cited by this paper
• Efficacy of Chinese traditional patent medicines for heart failure with preserved ejection fraction: a Bayesian network meta-analysis of 64 randomized controlled trials

  2023cited by this paper
• Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis)

  2023cited by this paper
• C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease.

  2023cited by this paper
• NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs.

  2023cited by this paper
• Whole-genome CRISPR screen identifies RAVER1 as a key regulator of RIPK1-mediated inflammatory cell death, PANoptosis

  2023cited by this paper
• Echinacea Polyphenols Inhibit NLRP3-Dependent Pyroptosis, Apoptosis, and Necroptosis via Suppressing NO Production during Lipopolysaccharide-Induced Acute Lung Injury.

  2023cited by this paper
• Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity

  2023cited by this paper
• ZBP1 Protects Against mtDNA-Induced Myocardial Inflammation in Failing Hearts

  2023cited by this paper
• Time-Course Transcriptomic Analysis Reveals the Crucial Roles of PANoptosis in Fungal Keratitis

  2023cited by this paper
• Salmonella effector SopF regulates PANoptosis of intestinal epithelial cells to aggravate systemic infection

  2023cited by this paper
• Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease

  2023cited by this paper
• GSK2795039 prevents RIP1-RIP3-MLKL-mediated cardiomyocyte necroptosis in doxorubicin-induced heart failure through inhibition of NADPH oxidase-derived oxidative stress.

  2023cited by this paper
• ADAR1 and ZBP1 in innate immunity, cell death, and disease.

  2023cited by this paper
• GSDMD-mediated pyroptosis dominantly promotes left ventricular remodeling and dysfunction in post-myocardial infarction: a comparison across modes of programmed cell death and mitochondrial involvement

  2023cited by this paper
• FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM

  2022cited by this paper
• The chemical components, action mechanisms, and clinical evidences of YiQiFuMai injection in the treatment of heart failure

  2022cited by this paper
• Hydrogen sulfide protects against ischemic heart failure by inhibiting RIP1/RIP3/MLKL-mediated necroptosis.

  2022cited by this paper
• Landscape of RNA-binding proteins in diagnostic utility, immune cell infiltration and PANoptosis features of heart failure

  2022cited by this paper
• ZBP1: A Powerful Innate Immune Sensor and Double-Edged Sword in Host Immunity

  2022cited by this paper
• Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor of Receptor Interacting Protein Kinase 3 Alleviates Necroptosis in Glycation End Products-Induced Cardiomyocytes Injury

  2022cited by this paper
• Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial

  2022cited by this paper
• Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation.

  2022cited by this paper
• ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection

  2022cited by this paper
• Necroptosis in heart disease: Molecular mechanisms and therapeutic implications.

  2022cited by this paper
• GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway

  2022cited by this paper
• Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications

  2022cited by this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cited by this paper
• STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS)

  2022cited by this paper
• NLRC4 Deficiency Leads to Enhanced Phosphorylation of MLKL and Necroptosis

  2022cited by this paper
• Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat.

  2022cited by this paper
• Dapagliflozin attenuates pressure overload-induced myocardial remodeling in mice via activating SIRT1 and inhibiting endoplasmic reticulum stress

  2021cited by this paper
• ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis.

  2021cited by this paper
• Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1–RIPK3-Dependent Pathway in Mice

  2021cited by this paper
• From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways

  2021cited by this paper
• AIM2 forms a complex with Pyrin and ZBP1 to drive PANoptosis and host defense

  2021cited by this paper
• Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth

  2021cited by this paper
• The 'cytokine storm': molecular mechanisms and therapeutic prospects.

  2021cited by this paper
• Necroptosis, pyroptosis and apoptosis: an intricate game of cell death

  2021cited by this paper
• Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice.

  2021cited by this paper
• Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017.

  2021cited by this paper
• Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation

  2021cited by this paper
• RIP1-dependent linear and nonlinear recruitments of caspase-8 and RIP3 respectively to necrosome specify distinct cell death outcomes

  2021cited by this paper
• The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression

  2021cited by this paper
• The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer

  2020cited by this paper
• DNA Sensing in the Innate Immune Response.

  2020cited by this paper
• Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis.

  2020cited by this paper
• Inflammation in Heart Failure: JACC State-of-the-Art Review.

  2020cited by this paper
• TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway

  2020cited by this paper
• NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy

  2020cited by this paper
• Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense.

  2020cited by this paper
• The Zα2 domain of ZBP1 is a molecular switch regulating influenza-induced PANoptosis and perinatal lethality during development

  2020cited by this paper
• Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)

  2020cited by this paper
• The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)

  2020cited by this paper
• Plasma Concentration of Receptor-Interacting Protein Kinase-3 as a Potential Biomarker for Diagnosis and Prognosis in Heart Failure.

  2020cited by this paper
• Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target

  2020cited by this paper
• Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload

  2020cited by this paper
• Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure

  2020cited by this paper
• ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis)

  2020cited by this paper
• Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway

  2020cited by this paper
• RIPK1 Distinctly Regulates Yersinia-Induced Inflammatory Cell Death, PANoptosis.

  2020cited by this paper
• Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes

  2020cited by this paper
• Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis

  2019cited by this paper
• Activity of caspase-8 determines plasticity between cell death pathways

  2019cited by this paper
• Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes.

  2019cited by this paper
• Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity–independent pyroptosis, apoptosis, necroptosis, and inflammatory disease

  2019cited by this paper
• Various aspects of inflammation in heart failure

  2019cited by this paper
• ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis)

  2019cited by this paper
• Exosome Treatment Enhances Anti-Inflammatory M2 Macrophages and Reduces Inflammation-Induced Pyroptosis in Doxorubicin-Induced Cardiomyopathy

  2019cited by this paper
• Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis

  2019cited by this paper
• Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies

  2019cited by this paper
• Role of AIM2 inflammasome in inflammatory diseases, cancer and infection

  2019cited by this paper
• Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation

  2019cited by this paper
• Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways.

  2019cited by this paper
• Single Cell Sequencing of Mouse Heart Immune Infiltrate in Pressure Overload-Driven Heart Failure Reveals Extent of Immune Activation.

  2019cited by this paper

• Novel diagnostic and therapeutic strategies based on PANoptosis for hepatocellular carcinoma

  2025cites this paper
• PANoptosis: Potential Therapeutic Prospects in Alzheimer's Disease

  2025cites this paper